借助"平台政策+流量扶持+增长策略"，京东买药秒送为合作商家打造了从运营到增长的全链路解决方 案。2025年京东APP首页"秒送外卖"标签升级，"24h送药"入口跃升至首屏显著位置，直接带动买药秒 送订单量暴涨3倍。京东618期间，京东买药秒送迎来爆发式增长，订单量同比增长超4倍，新增用户数 同比增长超6倍。众多数据印证了全域流量对合作商家生意增长的强劲拉动。2026年春节期间，京东买 药秒送在29个城市重点保供，为商家提供运费补贴与返佣支持，同时聚焦19个旅游热门城市推出近200 款商品补贴促销。在保障民生用药需求的同时，也为合作商家开辟了新的增长点。 新京报讯（记者王卡拉）京东买药秒送2月9日发布的数据显示，2025年合作门店数同比增长超100%， 服务网络已覆盖490个城市，订单量同比增长超200%，合作工业品牌数量同比增长超11倍。通过整合平 台流量、精细化运营与数智化能力，京东买药秒送构建起覆盖全链路的赋能体系，已成为助力药店、药 企等合作伙伴实现持续增长的重要渠道。 针对药企，京东买药秒送通过构建完整的品牌增长路径，助力药企从"卖产品"升级为"传递健康价值"。 在渠道触达层面，京东买药秒送构建了全 ...

当前，健康消费正经历深刻的代际变迁。即时性、个性化、场景化的健康需求的快速增长，推动即时零 售从"风口"演变为医药健康行业的"新基础设施"。据商务部研究院发布的《即时零售行业发展报告 (2025)》预测，即时零售市场规模2030年将超2万亿元。其中，医药O2O赛道表现尤为亮眼，有望成为 药品零售的主要增长引擎。 京东买药秒送最新数据显示：2025年合作门店数同比增长超100%，服务网络已覆盖490个城市，订单量 同比增长超200%，合作工业品牌数量同比增长超11倍。京东买药秒送通过整合平台流量、精细化运营 与数智化能力，构建起覆盖全链路的赋能体系，已成为助力药店、药企等合作伙伴实现持续增长的重要 渠道。 共赢生态：商家增速超预期，平台与伙伴共成长 京东买药秒送通过"平台政策+流量扶持+增长策略"三大能力抓手，为合作商家打造了从运营到增长的 全链路解决方案。 京东买药秒送的全域流量灌溉已成为驱动合作商家生意增长的关键引擎。2025年京东APP首页"秒送外 卖"标签升级，"24h送药"入口跃升至首屏显著位置，直接带动买药秒送订单量暴涨3倍。京东618期间， 京东买药秒送迎来爆发式增长，订单量同比增长超4倍，新增用 ...

Core Insights - The health consumption sector is undergoing significant generational changes, with a rapid increase in immediate, personalized, and scenario-based health demands, transforming instant retail into a new infrastructure for the pharmaceutical and health industry [1] - The instant retail market is projected to exceed 2 trillion yuan by 2030, with the O2O pharmaceutical sector expected to be a major growth driver [1] Group 1: Business Growth and Strategies - JD's "Buy Medicine in Seconds" service has seen over 100% year-on-year growth in partnered stores and a 200% increase in order volume, with a network covering 490 cities [1] - The service's full-chain solution, including platform policies, traffic support, and growth strategies, has become a key engine for driving business growth for partner merchants [2] - During the 618 shopping festival, order volume for "Buy Medicine in Seconds" surged over 400% year-on-year, with new user numbers increasing by over 600% [2] Group 2: Merchant Support and Incentives - A merchant evaluation system has been introduced to help stores quickly identify operational weaknesses, with over 100 merchants participating in the incentive program in 2025 [3] - The platform provides various support measures for new merchants, including dedicated service guidance, advertising subsidies, and traffic support [3] Group 3: Brand Value and Market Positioning - JD's service is helping pharmaceutical companies transition from merely selling products to delivering health value, supported by a nationwide supply network and rapid delivery capabilities [4] - The platform's insights into consumer behavior and category trends assist pharmaceutical companies in optimizing product strategies [4] Group 4: Marketing and Consumer Engagement - JD has launched targeted marketing campaigns, such as the "Warm Winter Delivery" initiative, which significantly increased GMV and new customer acquisition [5] - The marketing efforts focus on addressing user pain points and enhancing brand trust through meaningful engagement [5] Group 5: Future Developments and Innovations - The pharmaceutical O2O market is entering a critical phase of "value co-creation," with JD planning to leverage its digital capabilities to empower partners further [6][7] - The "京医千询" medical model and AI-driven tools are set to enhance intelligent product selection and precise marketing for merchants [7] - Future policies will include reduced shipping costs and incentives for high-growth merchants, aiming to lower operational costs and enhance growth certainty [7]

Core Viewpoint - JD Health's "Flu Season Rider Protection Plan" aims to ensure the health and safety of delivery riders while enhancing the safety of drug delivery for users during the flu season [1][2] Group 1: Health and Safety Measures - The plan provides free flu protection supplies, including disinfectant wipes, masks, cold medicine, and disinfectant, to all riders to address their protective needs during the flu season [1] - Riders are encouraged to share protective supplies, such as masks, with those in urgent need, promoting health awareness during deliveries [1] - JD Health emphasizes the importance of riders adhering to safety protocols, including wearing masks and conducting self-disinfection before and after deliveries [1] Group 2: Commitment to Delivery Safety - The initiative reflects JD Health's commitment to the dual responsibility of ensuring rider health and user safety during the delivery process [2] - By strengthening the safety measures in the "last mile" of delivery, the company aims to provide users with a more secure and reassuring experience when purchasing medications [2] - The plan includes regular updates on flu prevention, health maintenance, and protective techniques to enhance riders' health management awareness and capabilities [1]

Core Viewpoint - The recent surge in flu cases has led to an increased demand for immediate drug delivery services, highlighting the importance of rider health and safety in ensuring reliable medication delivery [1][4]. Group 1: Health and Safety Initiatives - JD Health has launched the "Flu Season Rider Protection Plan" to provide comprehensive support for riders and users during the flu season [1][4]. - The plan includes free provision of flu protection supplies such as disinfectant wipes, masks, and cold medicine from brands like 999 and Haishi Haino [4][5]. - Riders are encouraged to share protective supplies with those in need during deliveries, fostering a sense of community health support [5]. Group 2: Rider Training and Awareness - JD Health promotes strict safety protocols for riders, including regular disinfection and mask-wearing before and after deliveries [5]. - The company will regularly provide health knowledge related to flu prevention and self-care to enhance riders' health management awareness and protective capabilities [5]. Group 3: Commitment to User Safety - The "Flu Season Rider Protection Plan" reflects a commitment to both rider health and user safety, ensuring that every medication delivery is conducted with added layers of protection [5]. - The initiative aims to create a controllable and reassuring delivery experience for users, emphasizing the importance of safe medication delivery during the flu season [5].

Core Insights - JD Health is focusing on building a sustainable growth ecosystem centered around "users, supply chain, and logistics" in the instant retail sector, as highlighted in their recent conference themed "Opening a New Chapter for the Future" [1][2] - The company has introduced a growth triangle model of "Supply × Experience × User" to provide partners with reliable growth opportunities [2] Market Trends - Health consumption is undergoing significant generational changes, with users under 30 years old accounting for a 16% year-on-year increase in JD's instant medicine delivery service, and student users increasing by 11.5% year-on-year [1] - Young consumers are driving a shift in health consumption towards immediacy, personalization, and contextualization, with rising demands in specific scenarios such as emergency medical aesthetics and travel-related health needs [1] Industry Growth Projections - The instant retail market is projected to exceed 1 trillion yuan by 2025, growing at a rate of 29%, and is expected to surpass 2 trillion yuan by 2030 [1] - The O2O (Online to Offline) segment in pharmaceuticals is anticipated to be a major growth engine in the retail market [1] Operational Capabilities - JD Health has established a comprehensive supply chain network covering over 2,600 counties and cities, supported by a logistics system with over 2 million couriers, enabling delivery in as fast as 9 minutes [2] - Since April 2025, the number of JD's instant medicine delivery stores has seen a continuous year-on-year growth of over 100%, with orders increasing by over 200% [2] Collaborative Success - The collaboration with partners like Hongyu Pharmaceutical has demonstrated the effectiveness of JD Health's instant delivery network, significantly reducing the turnover days for unsold products and enabling inventory sharing and traffic activation [2] Future Focus - Looking ahead to 2026, JD Health plans to concentrate on specialized sectors within instant retail and enhance its supply chain capabilities [3] - The company aims to further open its data capabilities, traffic resources, and operational tools to ecosystem partners, facilitating sustainable growth in the new instant retail landscape [3]

Core Insights - The conference themed "A New Chapter, Building the Future" highlighted the future trends of pharmaceutical instant retail and explored new paths for high-quality growth [1] - JD Health emphasized the importance of a user, supply chain, and logistics-centric ecosystem for instant retail, introducing a growth triangle model focused on supply, experience, and users [1] Group 1: Market Trends - Instant retail has become the main growth engine for the pharmaceutical health sector, driven by the rising health consciousness among younger consumers [2] - JD Health reported a 16% year-on-year increase in the proportion of users under 30 for its instant delivery service, with student users increasing by 11.5% year-on-year [2] - The market for instant retail is projected to exceed 1 trillion yuan by 2025, growing at a rate of 29%, and surpass 2 trillion yuan by 2030 [2] Group 2: Capability Building - JD Health is building a "super pharmaceutical supply chain" as the foundation for its instant retail capabilities, focusing on a growth triangle model of supply, experience, and users [3] - The supply side has achieved nationwide coverage with a network spanning over 2,600 counties and cities, supported by over 200,000 delivery personnel, enabling delivery in as fast as 9 minutes [3] - Since April 2025, the number of JD Health's instant delivery pharmacies has increased by over 100% year-on-year, with order volume growing over 200% [3] Group 3: User Engagement - JD Health leverages its base of over 600 million active users to enhance channel operations and search recommendation mechanisms, transitioning from "people finding medicine" to "medicine finding people" [4] - The company provides scenario-based marketing solutions aligned with seasonal diseases and major promotional events to improve user engagement and conversion rates [4] Group 4: Collaborative Growth - JD Health's collaboration with partners has demonstrated significant results, such as reducing inventory turnover days for partners like Hongyu Pharmaceutical through access to JD Health's instant delivery network [5] - The Asia-Pacific region is identified as a growth engine for the self-care market, with strong consumer demand in pain management and allergy relief [5] - Looking ahead to 2026, JD Health plans to focus on specialization in instant retail and will open up data capabilities, traffic resources, and operational tools to partners [5]

Core Insights - The flu season is currently at a peak, with significant increases in demand for flu medications reported by JD's medicine delivery platform [1] - The demand for antiviral drugs has surged dramatically, with specific products seeing exponential growth in sales [1] Group 1: Demand Surge - From November 17 to November 23, the sales of Oseltamivir increased by 4.5 times, and the sales of Sufentanil surged by 5 times [1] - The sales of flu test kits rose by 4.8 times, while cough and pain relief medications increased by over 3 times [1] - The overall transaction value for flu medications increased by 22 times year-on-year during the same period [1] Group 2: Specific Product Performance - Sufentanil and Kewai saw transaction values increase by over 40 times year-on-year, while Tamiflu's transaction value grew by 24 times [1] - Common cold and cough medication sales doubled year-on-year, with specific products like the Four Seasons Antiviral Mixture and Lianhua Qingwen capsules seeing sales increase by over 5 times [1] Group 3: Testing and Medical Services - The number of respiratory bacterial and viral testing orders increased by 66% week-on-week, with a positive detection rate rising to 68.2% [1] - The demand for home sampling services by professional nurses nearly doubled in the same period [1] - JD's online hospital reported a 51% week-on-week increase in consultations for fever-related symptoms, providing rapid professional support to users [1][2]

Core Insights - JD Health achieved record-breaking sales during the 2025 11.11 shopping festival, with over 7,000 brands doubling their transaction volume year-on-year, driven by a surge in health consumption and services [1][2] - The integration of a "super pharmaceutical supply chain" and advanced digital technologies, including medical AI models, has positioned JD Health as a powerful engine for the health industry, enhancing sales across various categories and solidifying its leading position in online health consumption [1][6] Health Consumption Trends - The overall health consumption awareness among consumers has significantly increased, leading to a diverse, refined, and intelligent consumption trend [2] - Over 2,500 pharmaceutical brands saw their transaction volumes double year-on-year, with original innovative drugs also experiencing similar growth, highlighting JD Health's role in improving accessibility to these products [2] Nutritional and Medical Device Sales - Nutritional consumption is undergoing a transformation towards scientific nutrition, with over 2,500 health supplement brands doubling their sales, and nearly 100 subcategories seeing over 100% growth [4] - Medical devices also saw substantial growth, with over 2,000 brands achieving over 100% year-on-year sales increase, and specific categories like dynamic blood glucose meters and respiratory machines also experiencing significant sales growth [4] Professional Health Services - The demand for professional health services is rising, with JD Health leveraging its "medical testing, diagnosis, and treatment" service model to meet diverse consumer needs [5] - The JD Internet Hospital has enhanced its online consultation services, achieving rapid response times and high user satisfaction rates, with over 90% of nutrition consultations handled by AI nutritionists [5] Expansion of Health Services - JD Health opened its first self-operated medical beauty store during the 11.11 event, attracting over 11,000 participants, and also expanded its health check centers and orthopedic clinics, with overall order volumes increasing significantly [6] - The company continues to link global health brands with Chinese consumers, aiming to make high-quality medical and health products more accessible [6]

Core Viewpoint - JD Health reported strong revenue growth and improved profitability in the first half of 2025, driven by increased sales of pharmaceutical and health products, as well as digital marketing services [1][2][3] Group 1: Financial Performance - In the first half of 2025, JD Health achieved revenue of 35.3 billion yuan, a year-on-year increase of 24.5% from 28.3 billion yuan [1] - The company's operating profit reached 2.127 billion yuan, up 105.5% year-on-year, while Non-IFRS operating profit was 2.483 billion yuan, a 56.7% increase [1][2] - Non-IFRS net profit grew by 35% to 3.57 billion yuan, with a net profit margin of 10.1%, reflecting a 0.8 percentage point increase year-on-year [2] Group 2: Revenue Breakdown - Product revenue from the sale of pharmaceuticals and health products amounted to 29.3 billion yuan, a 22.7% increase year-on-year, accounting for 83% of total revenue [1] - Digital marketing services revenue reached 6 billion yuan, a 34.4% increase, driven by a rise in the number of advertisers [1][2] Group 3: Strategic Developments - JD Health has established over 200,000 links to offline pharmacies for instant delivery and expanded online medical insurance payments to nearly 200 million people [2] - The company has partnered with Beijing Children's Hospital to create a dedicated pediatric pharmacy, enhancing prescription flow and insurance payment processes [2] - The introduction of AI technologies, including AI doctors and pharmacists, has served over 50 million users, indicating a significant advancement in service capabilities [3] Group 4: Future Outlook - The company is expected to benefit from the deepening application of medical AI and the "Healthy China" strategy, which is likely to release health demand [3] - Revenue forecasts for 2025-2027 have been adjusted to 70 billion, 80.5 billion, and 92.6 billion yuan, respectively, with net profit estimates revised to 5.5 billion, 6.5 billion, and 7.6 billion yuan [3]